LeMaitre Q3 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
- SanDisk upgraded at JPMorgan after investor day; shares climb
Lemaitre Vascular (LMAT) Misses Q3 EPS by 3c; Offers FY22 Guidance
October 27, 2022 4:29 PM EDTLemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.25, $0.03 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $39 million versus the consensus estimate of $40.06 million.
GUIDANCE:
Lemaitre Vascular sees FY2022 EPS of $1.02-$1.08, versus the consensus of $1.09.... More
